Trademark Search in Canada

EBONEV

View On IC.GC.CA

REGISTERED

on 17 Oct 2019

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

Serial Number

1786025 filed on 8^th Jun 2016

Registration Number

TMA1059383 registered on 17^th Oct 2019

Registration expiry Date

17^th Oct 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

EBONEV

Trademark usage description

human pharmaceuticals for the prevention or treatment of autoimmune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of autoimmune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; pain relief medications; and anti-infectives; human vaccines.

Classification kind code

Mark Details

Serial Number

1786025

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 29^th Sept 2017	Allowed
Submitted for opposition 51 on 29^th Sept 2017	Allowance Notice Sent
Submitted for opposition 42 on 14^th Jun 2017	Advertised
Submitted for opposition 26 on 25^th May 2017	Approved
Submitted for opposition 27 on 4^th Apr 2017	Approval Notice Sent
Submitted for opposition 22 on 20^th Dec 2016	Search Recorded
Submitted for opposition 20 on 20^th Dec 2016	Examiner's First Report
Submitted for opposition 31 on 10^th Jun 2016	Formalized
Submitted for opposition 30 on 8^th Jun 2016	Filed
Submitted for opposition 1 on 8^th Jun 2016	Created